Population
Megakaryocytes (lacking collagen receptors or treated with blocking antibodies)
Comparison
Collagen type I exposure and GPVI receptor… vs Other collagen types or untreated/wild-type…
Design
Preclinical
Authors
Loading...
May refine models of marrow platelet release; leaves open whether GPVI targeting affects thrombopoiesis in vivo.
Collagen type I selectively inhibits proplatelet formation via a Syk-independent GPVI signaling pathway, providing mechanistic insight into how premature platelet release is prevented in the bone marrow.
Semeniak et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: